Cyclandelate
Chemical compound
- C04AX01 (WHO)
- 3,3,5-trimethylcyclohexyl hydroxy(phenyl)acetate
- 456-59-7
- 2893
- DB04838 Y
- 2790 Y
- 4139O1OAY2
- D00286 Y
- CHEBI:3988 Y
- ChEMBL1480987
- DTXSID4022862
- Interactive image
- O=C(OC1CC(CC(C1)(C)C)C)C(O)c2ccccc2
InChI
- InChI=1S/C17H24O3/c1-12-9-14(11-17(2,3)10-12)20-16(19)15(18)13-7-5-4-6-8-13/h4-8,12,14-15,18H,9-11H2,1-3H3 Y
- Key:WZHCOOQXZCIUNC-UHFFFAOYSA-N Y
Cyclandelate is a vasodilator used in the treatment of claudication, arteriosclerosis and Raynaud's disease.[1] It is also used to treat nighttime leg cramps, and has been investigated for its effect against migraine. It is orally administered.
References
- ^ Smith AL (January 1965). "Cyclandelate (Cyclospasmol) in the Treatment of Peripheral Circulatory Diseases". Angiology. 16: 1–7. doi:10.1177/000331976501600101. PMID 14258038.
- v
- t
- e
- Non-selective
- Selective α1-blockers
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e